L&K Biomed Ltd.

KOSDAQ:A156100 Voorraadrapport

Marktkapitalisatie: ₩140.2b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

L&K Biomed Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Kang guk Jin

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO0.1%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Geen updates

Recent updates

L&K Biomed Ltd. (KOSDAQ:156100) Investors Are Less Pessimistic Than Expected

Aug 12
L&K Biomed Ltd. (KOSDAQ:156100) Investors Are Less Pessimistic Than Expected

Revenues Tell The Story For L&K Biomed Ltd. (KOSDAQ:156100)

Apr 16
Revenues Tell The Story For L&K Biomed Ltd. (KOSDAQ:156100)

L&K Biomed (KOSDAQ:156100) Is Making Moderate Use Of Debt

Mar 09
L&K Biomed (KOSDAQ:156100) Is Making Moderate Use Of Debt

A Look At The Fair Value Of L&K Biomed Ltd. (KOSDAQ:156100)

Nov 24
A Look At The Fair Value Of L&K Biomed Ltd. (KOSDAQ:156100)

CEO

Kang guk Jin (58 yo)

no data

Tenure

Kang Guk jin is CEO & Director of L&K Biomed Ltd.